Clinical trial
Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension…
NCT00345774 · Epix Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00345774 |
|---|---|
| Title | Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Short-Term Efficacy and Safety of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease |
| Lead sponsor | Epix Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease |
| Intervention type | Drug |
| Interventions | PRX-08066 |
| Enrollment | 72 |
| Start date | Jun 1, 2006 |
| Completion | Jun 1, 2007 |
| First posted | Jun 28, 2006 |
| Last update posted | May 29, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: